The DOI matches its Crossref record; 49 of the 51 references it cites were found in a registry or an index, and 2 are not checked yet.
PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2
Open accessAbstract
Excessive bone loss in arthritic diseases is mostly due to abnormal activation of the immune system leading to stimulation of osteoclasts. While phospholipase Cgamma (PLCgamma) isoforms are known modulators of T and B lymphocyte-mediated immune responses, we found that blockade of PLCgamma enzymatic activity also blocks early osteoclast development and function. Importantly, targeted deletion of Plcg2 in mice led to an osteopetrotic phenotype. PLCgamma2, independent of PLCgamma1, was required for receptor activator of NF-kappaB ligand-induced (RANKL-induced) osteoclastogenesis by differentially regulating nuclear factor of activated T cells c1 (NFATc1), activator protein-1 (AP1), and NF-kappaB. Specifically, we show that NFATc1 upregulation is dependent on RANKL-mediated phosphorylation of PLCgamma2 downstream of Dap12/Fc receptor gamma (Dap12/FcRgamma) receptors and is blocked by the PLCgamma inhibitor U73122. In contrast, activation of JNK and NF-kappaB was not affected by U73122 or Dap12/FcRgamma deletion. Interestingly, we found that in osteoclasts, PLCgamma2 formed a complex with the regulatory adapter molecule GAB2, was required for GAB2 phosphorylation, and modulated GAB2 recruitment to RANK. Thus, PLCgamma2 mediates RANKL-induced osteoclastogenesis and is a potential candidate for antiresorptive therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, PLCγ2-deficient mouse studies showed that blocking PLCγ2 impedes the early development and function of osteoclasts, thereby preventing bone loss in arthritis (99, 100).”
From The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration (2021) · cites this paper as [99]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“PLCγ2 is necessary for separation of blood and lymphatic vessels in mice (29) and osteoclastogenesis (42), and PLCγ2 outside of the brain has roles in immune deficiencies, autoimmunity, and cancer (18).”
From Multi-omics analyses reveal novel effects of PLCγ2 deficiency in the mouse brain (2023) · cites this paper as [42]
The cited source says what the claim attributes to it.
In the citing paper
“PLCG2 is highly expressed in the hematopoietic system.”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [11]
The cited source says what the claim attributes to it.
In the citing paper
“RANKL-induced osteoclastogenesis requires PLCγ2, which controls downstream functions including NFATc1, AP1, and NF-κB (99).”
From The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration (2021) · cites this paper as [99]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,720
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440
c-Fos: a Key Regulator of Osteoclast-Macrophage Lineage Determination and Bone Remodeling
Grigoriadis, A. E., Wang, Z., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., & Wagner, E. F. (1994) · Science · doi:10.1126/science.7939685 · Cited by 1,264
Structure, Function, and Control of Phosphoinositide-Specific Phospholipase C
Rebecchi, M. J., & Pentyala, S. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1291 · Cited by 1,000
Requirement for NF-κB in osteoclast and B-cell development
Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., & Siebenlist, U. (1997) · Genes & Development · doi:10.1101/gad.11.24.3482 · Cited by 996
Osteopetrosis in mice lacking NF-κB1 and NF-κB2
Iotsova, V., Caamaño, J., Loy, J. K., Yang, Y., Lewin, A. C., & Bravo, R. (1997) · Nature Medicine · doi:10.1038/nm1197-1285 · Cited by 990
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis
Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E. F., Mak, T. W., Serfling, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051150 · Cited by 849
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
Koga, T., Inui, M., Inoue, K., Kim, S., Suematsu, A., Kobayashi, E., Iwata, T., Ohnishi, H., Matozaki, T., Kodama, T., et al. (2004) · Nature · doi:10.1038/nature02444 · Cited by 832
Flagged first, then by citations
Research works printed but not linked: 2
- 10.1172/JCI200523394 · DOI
- Bleasdale, 1989, Adv. Prostaglandin Thromboxane Leukot. Res., 19, 590
Cited by
Sorted by citations
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Takayanagi, H. (2007) · Nature Reviews Immunology · doi:10.1038/nri2062 · Cited by 1,878
Current Understanding of RANK Signaling in Osteoclast Differentiation and Maturation
Park, J. H., Lee, N. K., & Lee, S. Y. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.0225 · Cited by 688
The cell biology of bone metabolism
Datta, H. K., Ng, W. F., Walker, J. A., Tuck, S. P., & Varanasi, S. S. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.048868 · Cited by 614
Regulation of NFATc1 in Osteoclast Differentiation
Kim, J. H., & Kim, N. (2014) · Journal of Bone Metabolism · doi:10.11005/jbm.2014.21.4.233 · Cited by 570
“[58] Well known inhibitors of calcineurin, such as FK506 and cyclosporine A, strongly inhibit RANKL-induced osteoclast differentiation by blocking NFATc1 translocation into the nucleus in vitro and in vivo.”
BackgroundOsteoimmunology: Interactions of the Bone and Immune System
Lorenzo, J., Horowitz, M. C., & Choi, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0038 · Cited by 576
Osteoimmunology: The conceptual framework unifying the immune and skeletal systems
Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A., Sawa, S., Nitta, T., & Takayanagi, H. (2017) · Physiological Reviews · doi:10.1152/physrev.00036.2016 · Cited by 534
The role of NFAT in osteoclast formation
TAKAYANAGI, H. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.071 · Cited by 442
TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1
Peng, Q., Malhotra, S., Torchia, J. A., Kerr, W. G., Coggeshall, K. M., & Humphrey, M. B. (2010) · Science Signaling · doi:10.1126/scisignal.2000500 · Cited by 413
RANK/RANKL: Regulators of Immune Responses and Bone Physiology
Leibbrandt, A., & Penninger, J. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.016 · Cited by 420
Ca 2+ ‐NFATc1 signaling is an essential axis of osteoclast differentiation
Negishi‐Koga, T., & Takayanagi, H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00821.x · Cited by 415
The Osteoclast: Friend or Foe?
Novack, D. V., & Teitelbaum, S. L. (2007) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.151431 · Cited by 402
Self-citationTyrosine Kinases Btk and Tec Regulate Osteoclast Differentiation by Linking RANK and ITAM Signals
Shinohara, M., Koga, T., Okamoto, K., Sakaguchi, S., Arai, K., Yasuda, H., Takai, T., Kodama, T., Morio, T., Geha, R. S., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.037 · Cited by 327
Wunderlich, P., Glebov, K., Kemmerling, N., Tien, N. T., Neumann, H., & Walter, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.517540 · Cited by 296
NFATc1: Functions in osteoclasts
Zhao, Q., Wang, X., Liu, Y., He, A., & Jia, R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.018 · Cited by 241
Andreone, B. J., Przybyla, L., Llapashtica, C., Rana, A., Davis, S. S., van Lengerich, B., Lin, K., Shi, J., Mei, Y., Astarita, G., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0650-6 · Cited by 233
Osteoimmunology: Crosstalk Between the Immune and Bone Systems
Nakashima, T., & Takayanagi, H. (2009) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9316-6 · Cited by 218
Cross-regulation of signaling by ITAM-associated receptors
Ivashkiv, L. B. (2009) · Nature Immunology · doi:10.1038/ni.1706 · Cited by 219
OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice
Barrow, A. D., Raynal, N., Andersen, T. L., Slatter, D. A., Bihan, D. G., Pugh, N., Cella, M., Kim, T. S., Rho, J., Negishi‐Koga, T., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45913 · Cited by 207
Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis
Braun, T., & Zwerina, J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3380 · Cited by 208
Molecular mechanisms and clinical management of cancer bone metastasis
Wang, M., Xia, F., Wei, Y., & Wei, X. (2020) · Bone Research · doi:10.1038/s41413-020-00105-1 · Cited by 204
A RANKL–PKCβ–TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclastsPreprint
Ferron, M., Settembre, C., Shimazu, J., Lacombe, J., Kato, S., Rawlings, D. J., Ballabio, A., & Karsenty, G. (2013) · Genes & Development · doi:10.1101/gad.213827.113 · Cited by 187
Irie, N., Takada, Y., Watanabe, Y., Matsuzaki, Y., Naruse, C., Asano, M., Iwakura, Y., Suda, T., & Matsuo, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807598200 · Cited by 182
Nagy, V., & Penninger, J. M. (2015) · Gerontology · doi:10.1159/000371845 · Cited by 175
Function, regulation and pathological roles of the Gab/DOS docking proteins
Wöhrle, F. U., Daly, R. J., & Brummer, T. (2009) · Cell Communication and Signaling · doi:10.1186/1478-811x-7-22 · Cited by 171
TREM2 and β-Catenin Regulate Bone Homeostasis by Controlling the Rate of Osteoclastogenesis
Otero, K., Shinohara, M., Zhao, H., Cella, M., Gilfillan, S., Colucci, A., Faccio, R., Ross, F. P., Teitelbaum, S. L., Takayanagi, H., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102836 · Cited by 177
Self-citationTargeting strategies for bone diseases: signaling pathways and clinical studies
Xu, H., Wang, W., Liu, X., Huang, W. H., Chen, Z., Xu, Y., Yang, H., Bai, J., & Geng, D. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01467-8 · Cited by 177
Periodontitis and type II diabetes: a two-way relationship
Chee, B., Park, B., & Bartold, P. M. (2013) · International Journal of Evidence-Based Healthcare · doi:10.1111/1744-1609.12038 · Cited by 155
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
Nizami, S., Hall‐Roberts, H., Warrier, S., Cowley, S. A., & Di Daniel, E. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14618 · Cited by 147
Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
Magno, L., Lessard, C. B., Martins, M., Lang, V., Cruz, P., Asi, Y., Katan, M., Bilsland, J., Lashley, T., Chakrabarty, P., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0469-0 · Cited by 143
Decreased osteoclastogenesis in serotonin-deficient mice
Chabbi-Achengli, Y., Coudert, A. E., Callebert, J., Geoffroy, V., Côté, F., Collet, C., & de Vernejoul, M. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117792109 · Cited by 146
OsteoimmunologyPreprint
Okamoto, K., & Takayanagi, H. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031245 · Cited by 146
Yang, S., & Li, Y. (2007) · Genes & Development · doi:10.1101/gad.1544107 · Cited by 138
Yarilina, A., Xu, K., Chen, J., & Ivashkiv, L. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010030108 · Cited by 138
Kameda, Y., Takahata, M., Komatsu, M., Mikuni, S., Hatakeyama, S., Shimizu, T., Angata, T., Kinjo, M., Minami, A., & Iwasaki, N. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1989 · Cited by 128
Park‐Min, K., Ji, J.-D., Antoniv, T. T., Reid, A. C., Silver, R. B., Humphrey, M. B., Nakamura, M. C., & Ivashkiv, L. B. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804165 · Cited by 123
Immunoreceptor-like signaling by β2 and β3 integrins
Jakus, Z., Fodor, S., Abram, C., Lowell, C., & Mócsai, A. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.09.001 · Cited by 112
The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration
Jackson, J. T., Mulazzani, E., Nutt, S. L., & Masters, S. L. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100905 · Cited by 113
“Murine macrophages lacking PLCγ2 are also defective in the pattern recognition receptor for fungal cell walls, dectin-2 signaling in response to fungal infections as highlighted by reduced inflammatory cytokine responses, NF-κB and MAPK signaling, ROS, and clearance of fungal infections in vivo (81).”
BackgroundInfluentialFarber, C. R., Bennett, B. J., Orozco, L. D., Zou, W., Lira, A. K., Kostem, E., Kang, H. M., Furlotte, N. A., Berberyan, A., Ghazalpour, A., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002038 · Cited by 116
Mechanisms involved in normal and pathological osteoclastogenesis
Park‐Min, K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2817-9 · Cited by 126
The role of SH3BP2 in the pathophysiology of cherubism
Reichenberger, E., Levine, M. A., Olsen, B. R., Papadaki, M. E., & Lietman, S. A. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-s1-s5 · Cited by 110
The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast Maturation
Lee, S. H., Kim, T. S., Jeong, D., Kim, N., & Choi, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708935200 · Cited by 106
Danks, L., & Takayanagi, H. (2013) · The Journal of Biochemistry · doi:10.1093/jb/mvt049 · Cited by 103
Joyce-Shaikh, B., Bigler, M. E., Chao, C., Murphy, E. E., Blumenschein, W. M., Adamopoulos, I. E., Heyworth, P. G., Antonenko, S. V., Bowman, E. P., McClanahan, T. K., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20090516 · Cited by 103
Osteoclast Signal Transduction During Bone Metastasis Formation
Győri, D., & Mócsai, A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00507 · Cited by 107
The Role of Ca2+-NFATc1 Signaling and Its Modulation on Osteoclastogenesis
Kang, J. Y., Kang, N., Yang, Y., Hong, J. H., & Shin, D. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103646 · Cited by 96
Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytes
Mun, S. H., Ko, N. Y., Kim, H. S., Kim, J. W., Kim, D. K., Kim, A., Lee, S. H., Kim, Y., Lee, C. K., Lee, S. H., et al. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0410-y · Cited by 98
Osteoclast motility: Putting the brakes on bone resorption
Novack, D. V., & Faccio, R. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.09.005 · Cited by 93
Self-citationOsteoclasts and the immune system
Nakashima, T., & Takayanagi, H. (2009) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-009-0089-z · Cited by 88
GAB2—a Scaffolding Protein in Cancer
Adams, S. J., Aydin, I. T., & Celebi, J. T. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0352 · Cited by 88
CD8+ T Cells Regulate Bone Tumor Burden Independent of Osteoclast Resorption
Zhang, K., Kim, S., Cremasco, V., Hirbe, A. C., Novack, D. V., Weilbaecher, K. N., & Faccio, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3922 · Cited by 82
Self-citationSignal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12
Inui, M., Kikuchi, Y., Aoki, N., Endo, S., Maeda, T., Sugahara–Tobinai, A., Fujimura, S., Nakamura, A., Kumanogoh, A., Colonna, M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900463106 · Cited by 77
3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions
Levaot, N., Simoncic, P. D., Dimitriou, I. D., Scotter, A. J., Rose, J. L., Ng, A., Willett, T. L., Wang, C. J., Janmohamed, S., Grynpas, M. D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45843 · Cited by 75
RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations
Kajiya, H., Okamoto, F., Nemoto, T., 来海, 慶., Goto-T, K., Nakayana, S., & Okabe, K. (2010) · Cell Calcium · doi:10.1016/j.ceca.2010.09.010 · Cited by 75
Osteoclasts—Key Players in Skeletal Health and Disease
Novack, D. V., & Mbalaviele, G. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0011-2015 · Cited by 80
Self-citationThe dynamic interplay between osteoclasts and the immune system
Nakashima, T., & Takayanagi, H. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.04.004 · Cited by 72
Mebarek, S., Abousalham, A., Magne, D., Do, L.-D., Bandorowicz‐Pikuła, J., Pikuła, S., & Buchet, R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035036 · Cited by 73
Stuible, M., Moraitis, A. N., Fortin, A., Saragosa, S., Kalbakji, A., Filion, M., & Tremblay, G. B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.494542 · Cited by 72
Shaheen, S., Wan, Z., Li, Z., Chau, A., Li, X., Zhang, S., Liu, Y., Yi, J., Zeng, Y., Wang, J., et al. (2017) · eLife · doi:10.7554/elife.23060 · Cited by 69
Epple, H., Cremasco, V., Zhang, K., Mao, D., Longmore, G. D., & Faccio, R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00259-08 · Cited by 64
Self-citationMukai, T., Ishida, S., Ishikawa, R., Yoshitaka, T., Kittaka, M., Gallant, R., Lin, Y., Rottapel, R. K., Brotto, M., Reichenberger, E., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2295 · Cited by 64
Novel osteoclast signaling mechanisms
Shinohara, M., & Takayanagi, H. (2007) · Current Osteoporosis Reports · doi:10.1007/s11914-007-0005-1 · Cited by 72
Kim, J., Cheon, Y., Oh, H. M., Rho, M., Erkhembaatar, M., Kim, M. S., Lee, C. H., Kim, J. J., Choi, M. K., Yoon, K., et al. (2013) · Bone · doi:10.1016/j.bone.2013.12.013 · Cited by 59
RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis
Li, S., Miller, C. H., Γιαννοπούλου, Ε., Hu, X., Ivashkiv, L. B., & Zhao, B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71882 · Cited by 59
Calcium Homeostasis: A Potential Vicious Cycle of Bone Metastasis in Breast Cancers
Yang, Z., Yue, Z., Ma, X., & Xu, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00293 · Cited by 57
RANKL/RANK as Key Factors for Osteoclast Development and Bone Loss in Arthropathies
Leibbrandt, A., & Penninger, J. M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-0298-6_7 · Cited by 54
Osteoimmunology: the expanding role of immunoreceptors in osteoclasts and bone remodeling
Long, C. L., & Humphrey, M. B. (2012) · BoneKEy Reports · doi:10.1038/bonekey.2012.59 · Cited by 53
The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo
Kim, H. J., Zhang, K., Zhang, L., Ross, F. P., Teitelbaum, S. L., & Faccio, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806963106 · Cited by 52
Self-citationWang, C., Xiao, F., Qu, X., Zhai, Z., Hu, G., Chen, X., & Zhang, X. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00407 · Cited by 51
Cremasco, V., Graham, D. B., Novack, D. V., Swat, W., & Faccio, R. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23757 · Cited by 51
Self-citationGenes and Pathways Associated with Skeletal Sagittal Malocclusions: A Systematic Review
Gershater, E., Li, C., Ha, P., Chung, C., Tanna, N. K., Zou, M., & Zheng, Z. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313037 · Cited by 49
Liu, Y., Han, X., Bo, J.-X., & Ma, H. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00375 · Cited by 48
Modarresi, R., Xiang, Z., Yin, M. T., & Laurence, J. C. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080484 · Cited by 49
Abe, K., Fuchs, H., Boersma, A., Hans, W., Yu, P., Kalaydjiev, S., Klaften, M., Adler, T., Calzada‐Wack, J., Mossbrugger, I., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30280 · Cited by 46
Regulation of osteoclasts by membrane-derived lipid mediators
Oikawa, T., Kuroda, Y., & Matsuo, K. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1238-4 · Cited by 50
Jia, Y., Miao, Y., Yue, M., Shu, M., Wei, Z., & Dai, Y. (2018) · The FASEB Journal · doi:10.1096/fj.201701148rr · Cited by 45
Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
Takatori, S., Wang, W., Iguchi, A., & Tomita, T. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-05542-4_5 · Cited by 44
The Gab2–MALT1 axis regulates thromboinflammation and deep vein thrombosis
Kondreddy, V. K. R., Keshava, S., Das, K., Magisetty, J., Rao, L. V. M., & Pendurthi, U. R. (2022) · Blood · doi:10.1182/blood.2022016424 · Cited by 46
Lysosomal Ca2+ Signaling is Essential for Osteoclastogenesis and Bone Remodeling
Erkhembaatar, M., Gu, D. R., Lee, S. H., Yang, Y., Park, S., Muallem, S., Shin, D. M., & Kim, M. S. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2986 · Cited by 44
Maffucci, T., Raimondi, C., Abu‐Hayyeh, S., Dominguez, V., Sala, G., Zachary, I. C., & Falasca, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008285 · Cited by 42
Kim, J., Park, S., Baek, J. M., Erkhembaatar, M., Kim, M. S., Yoon, K., Oh, J., & Lee, M. S. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00233 · Cited by 41
Shin, H.-S., Sarin, R., Dixit, N., Wu, J., Gershwin, E. M., Bowman, E. P., & Adamopoulos, I. E. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401013 · Cited by 41
SH3BP2 is an activator of NFAT activity and osteoclastogenesis
Lietman, S. A., Yin, L., & Levine, M. A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.080 · Cited by 41
Tmem178 acts in a novel negative feedback loop targeting NFATc1 to regulate bone mass
Decker, C. E., Yang, Z., Rimer, R., Park‐Min, K., Macaubas, C., Mellins, E., Novack, D. V., & Faccio, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511285112 · Cited by 37
Self-citationMolecular mechanisms of triggering, amplifying and targeting RANK signaling in osteoclasts
Kuroda, Y. (2012) · World Journal of Orthopedics · doi:10.5312/wjo.v3.i11.167 · Cited by 42
Cremasco, V., Benasciutti, E., Cella, M., Kisseleva, M. V., Croke, M., & Faccio, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008909 · Cited by 39
Self-citationGPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass
Menon, P., Yin, G., Smolock, E. M., Zuscik, M. J., Chen, Y., & Berk, B. C. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22282 · Cited by 38
Rustagi, Y., Abouhashem, A. S., Verma, P., Verma, S. S., Hernandez, E., Liu, S., Kumar, M., Guda, P. R., Srivastava, R., Mohanty, S. K., et al. (2022) · Diabetes · doi:10.2337/db21-0830 · Cited by 37
Guezguez, A., Prod’homme, V., Mouska, X., Baudot, A. D., Blin‐Wakkach, C., Rottapel, R. K., & Deckert, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091124 · Cited by 39
Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis
Choi, H. K., Kang, H. R., Jung, E., Kim, T. E., Lin, J., & Lee, S. Y. (2013) · Cell Research · doi:10.1038/cr.2013.33 · Cited by 35
Roles of Phospholipase C Isozymes in Organogenesis and Embryonic Development
Nakamura, Y., & Fukami, K. (2009) · Physiology · doi:10.1152/physiol.00031.2009 · Cited by 36
STAC2 negatively regulates osteoclast formation by targeting the RANK signaling complex
Jeong, E., Choi, H. K., Park, J. H., & Lee, S. Y. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0048-5 · Cited by 35
Alteration of RANKL-Induced Osteoclastogenesis in Primary Cultured Osteoclasts From SERCA2+/− Mice
Yang, Y., Kim, M. S., Son, A., Hong, J. H., Kim, K., Seo, J. T., Lee, S.-I., & Shin, D. M. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090420 · Cited by 35
The role of calcium channels in osteoporosis and their therapeutic potential
Hao, Y., Yang, N., Sun, M., Yang, S., & Chen, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1450328 · Cited by 42
Ca2+-Dependent Regulation of NFATc1 via KCa3.1 in Inflammatory Osteoclastogenesis
Grössinger, E. M., Kang, M., Bouchareychas, L., Sarin, R., Haudenschild, D. R., Borodinsky, L. N., & Adamopoulos, I. E. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701170 · Cited by 32
Phospholipase Cγ2 is required for basal but not oestrogen deficiency–induced bone resorption
Kertész, Z., Győri, D., Körmendi, S., Fekete, T., Kis‐Tóth, K., Jakus, Z., Schett, G. A., Rajnavölgyi, É., Dobó‐Nagy, C., & Mócsai, A. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02556.x · Cited by 33
A unique domain in RANK is required for Gab2 and PLCγ2 binding to establish osteoclastogenic signals
Taguchi, Y., Gohda, J., Koga, T., Takayanagi, H., & Inoue, J. (2009) · Genes to Cells · doi:10.1111/j.1365-2443.2009.01351.x · Cited by 34
Jawing about TNF: New Hope for Cherubism
Novack, D. V., & Faccio, R. (2007) · Cell · doi:10.1016/j.cell.2006.12.019 · Cited by 32
Self-citationInteraction between the skeletal and immune systems in cancer: mechanisms and clinical implications
Terpos, E., & Dimopoulos, M. A. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-0974-x · Cited by 31
Csete, D., Simon, E., Alatshan, A., Aradi, P., Dobó‐Nagy, C., Jakus, Z., Benkő, S., Győri, D., & Mócsai, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00937 · Cited by 30
Immune regulation of the tumor/bone vicious cycle
Faccio, R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06244.x · Cited by 30
Self-citation
Metadata
- Authors
- Mao, D., Epple, H., Uthgenannt, B., Novack, D. V., & Faccio, R.
- Affiliations
- Washington University in St. Louis (US)
- Barnes-Jewish Hospital (US)
- Corresponding author
- Faccio, Roberta
- Venue
- Journal of Clinical Investigation
- Published
- 2006-11-01
- Volume
- 116
- Issue
- 11
- Pages
- 2869-2879
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1616195
- OpenAlex
- W2166456614
- Cited by
- 214
- References
- 49
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 6 · 2023: 5 · 2022: 5 · 2021: 11 · 2020: 13 · 2019: 10 · 2018: 8 · 2017: 15 · 2016: 9 · 2015: 11 · 2014: 12 · 2013: 15 · 2012: 15
- FWCI
- 5.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Funders
- Arthritis Foundation
- Cancer Research UK
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR47846, AR 48335, AR52921, P30AR048335, K08AR047846)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
- Keywords
- PLCγ2, osteoclastogenesis, RANKL, ITAM, Gab2, NFATc1, NF-κB, JNK, osteopetrosis, bone resorption, arthritis, antiresorptive therapy, U73122
- MeSH terms
- Actins, Animals, Cell Differentiation, Cells, Cultured, Mice, Inbred C57BL, Osteoclasts, Osteogenesis, Phosphoproteins, Protein Binding, Receptors, Immunologic, Tyrosine, Signal Transduction, Bone Density, NF-kappa B, Phosphorus Compounds, Mice, Knockout, Transcription Factor AP-1, Protein Kinase Inhibitors, Adaptor Proteins, Signal Transducing, Mice, I-kappa B Kinase, Phospholipase C gamma, RANK Ligand
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
